S-8 1 forms-8.htm

 

As filed with the Securities and Exchange Commission on March 29, 2023

 

Registration No. 333-

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 

 

 

Provention Bio, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of

incorporation or organization)

 

81-5245912

(I.R.S. Employer

Identification No.)

 

55 Broad Street, 2nd Floor

Red Bank, New Jersey 07701

(Address of Principal Executive Offices) (Zip Code)

 

Provention Bio, Inc. Amended and Restated 2017 Equity Incentive Plan

(Full title of the plan)

 

Ashleigh Palmer

Chief Executive Officer

Provention Bio, Inc.

55 Broad Street, 2nd Floor

Red Bank, New Jersey 07701

(908) 336-0360

(Name, address and telephone number, including area code, of agent for service)

 

with copies to:

 

Thomas J. Danielski

Ropes & Gray LLP

800 Boylston Street

Boston, Massachusetts 02199

(617) 951-7000

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
 

 

 

 

 

 

EXPLANATORY NOTE

 

This Registration Statement is being filed to register an additional 7,186,283 shares of the registrant’s common stock for issuance under the Amended and Restated Provention Bio, Inc. 2017 Equity Incentive Plan. Pursuant to General Instruction E to Form S-8, the registrant incorporates by reference, except to the extent supplemented, amended or superseded by the information set forth herein, into this Registration Statement the entire contents of its Registration Statement on Form S-8 (File No. 333-226814) filed with the Securities and Exchange Commission on August 13, 2018, its Registration Statement on Form S-8 (File No. 333-230400) filed with the Securities and Exchange Commission on March 19, 2019, its Registration Statement on Form S-8 (File No. 333-237113) filed with the Securities and Exchange Commission on March 12, 2020, its Registration Statement on Form S-8 (File No. 333-253657) filed with the Securities and Exchange Commission on February 26, 2021 and its Registration Statement on Form S-8 (File No. 333-262945) filed with the Securities and Exchange Commission on February 24, 2022.

 

 

 

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8.Exhibits

 

Exhibit
Number
  Description
3.1   Second Amended and Restated Certificate of Incorporation of Provention Bio, Inc., effective as of July 19, 2018 (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed with the Securities and Exchange Commission on July 19, 2018)

3.2

 

Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Provention Bio, Inc., effective as of May 13, 2021 (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed with the Securities and Exchange Commission on May 14, 2021)

3.3   Amended and Restated Bylaws of Provention Bio, Inc., as adopted on May 9, 2023 (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed with the Securities and Exchange Commission on March 13, 2023)
4.1   Provention Bio, Inc. Amended and Restated 2017 Equity Incentive Plan (incorporated by reference to Exhibit 4.4 to the registrant’s Form S-8 Registration Statement filed with the Securities and Exchange Commission on August 13, 2018)
4.2   Form of Stock Option Award under 2017 Provention Bio, Inc. Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to the registrant’s Form S-1 Registration Statement filed with the Securities and Exchange Commission on May 9, 2018)
5.1   Opinion of Ropes & Gray LLP
23.1   Consent of EisnerAmper LLP
23.2   Consent of Ropes & Gray LLP (included in Exhibit 5.1)
24.1   Power of Attorney (included on the signature page of this Registration Statement under the caption “Power of Attorney”)
107   Filing Fee Table

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Red Bank, State of New Jersey, on March 29, 2023.

 

  Provention Bio, Inc.
     
  By: /s/ Ashleigh Palmer
    Ashleigh Palmer
    Chief Executive Officer

 

POWER OF ATTORNEY

 

Each person whose signature appears below constitutes and appoints Ashleigh Palmer, Thierry Chauche and Heidy King-Jones, and each of them acting individually, his or her true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue hereof.

 

* * * *

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

Signature   Title   Date
         
/s/ Ashleigh Palmer   Chief Executive Officer and Director   March 29, 2023
Ashleigh Palmer   (Principal Executive Officer)    
         
/s/ Thierry Chauche   Chief Financial Officer   March 29, 2023
Thierry Chauche   (Principal Financial Officer)    
         
/s/ Justin Vogel   Chief Accounting Officer   March 29, 2023
Justin Vogel   (Principal Accounting Officer)    
         
/s/ Avery Catlin   Director   March 29, 2023
Avery Catlin        
         
/s/ Rita Jain   Director   March 29, 2023
Rita Jain        
         
/s/ John Jenkins, MD   Director   March 29, 2023
John Jenkins, MD        
         
/s/ Wayne Pisano   Director   March 29, 2023
Wayne Pisano        
         
/s/ Nancy Wysenski   Director   March 29, 2023
Nancy Wysenski